1 / 4

Phenylketonuria Treatment Market

The phenylketonuria (PKU) treatment market is anticipated to grow at a lucrative growth during the forecast period. PKU is a genetic metabolism defect that results in decreased metabolism of the amino acid called phenylalanine. PKU has no definite cure yet, it can only be managed using additional therapy and diet controls. Unmanaged PKU can lead to various intellectual disability, seizures, behavioral and mental disorders in children. <br>

Saifiyan
Download Presentation

Phenylketonuria Treatment Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Phenylketonuria Treatment Market Size, Growth Analysis Report, Forecast to 2027 Phenylketonuria Treatment Market: Report Based on Development, Scope, Share, Trends, Forecast to 2027 Phenylketonuria Segmentation, Outlook, Industry Report to 2021-2027 Treatment Market Trends | The phenylketonuria (PKU) treatment market is anticipated to grow at a lucrative growth during the forecast period. PKU is a genetic metabolism defect that results in decreased metabolism of the amino acid called phenylalanine. PKU has no definite cure yet, it can only be managed using additional therapy and diet controls. Unmanaged PKU can lead to various intellectual disability, seizures, behavioral and mental disorders in children. In 2019, the global phenylketonuria treatment market was more than $570 million with a growth of around 22% YoY. Kuvan is a major drug for the treatment of phenylketonuria however by the fourth quarter of 2020, its generic version will be available in the US market. Due to these, a drop in the growth can be witnessed in the near future. The patent expiration offers considerable opportunities to the new market players in the US, Europe, and other regulated market. Get Free Sample Copy @ https://www.omrglobal.com/request-sample/phenylketonuria- treatment-market Moreover, the surge in the use of various gene and targeted therapy for the management of PKU is anticipated to significantly drive the phenylketonuria treatment market. In addition, the increasing R&D activities for the development of new effective drugs are also expected to fuel the growth of the phenylketonuria treatment market. In addition to this, pipeline drugs such as SYNB1618 and many more will also present new opportunities for the further expansion of the global phenylketonuria treatment market. A https://www.omrglobal.com/industry-reports/phenylketonuria-treatment-market Full Report of Phenylketonuria Treatment Market is Available at:

  2. The global phenylketonuria treatment market is segmented based on drug type. The market is sub-segmented into kuvan, playnziq, and others. Among these, the kuvan sub-segment is anticipated to hold the largest market share during the forecast period. Kuvan was approved for the treatment of PKU by the US FDA in December 2007 and by the EU in December 2008. However, the drug will start to lose its patent from 2020. Playnziq is expected to show a significant growth rate during the forecast period as it was approved in May 2018 and will not lose any patent until 2025. Other segments will also segment with a lucrative growth with opportunities in new drug discoveries for the treatment of PKU during the forecast period. Phenylketonuria Treatment Market Segmentation Global Phenylketonuria Treatment Market by Drug Type •Kuvan •Playnziq •Others Phenylketonuria Treatment Market – Segment by Region North America •United States •Canada Europe •Germany •United Kingdom •France •Spain •Italy •Rest of Europe Asia-Pacific •China

  3. •Japan •India •Rest of Asia-Pacific Rest of the World •Latin America •Middle East and Africa Company Profiles •American Gene Technologies Inc. •APR Applied Pharma Research s.a. •BioMarin Pharmaceutical Inc. •Censa Pharmaceuticals Inc. •Codexis, Inc. •Daiichi Sankyo Co.Ltd. •Erytech Pharma SA •Generation Bio Co. •Homology Medicines, Inc. •Nestlé Health Science •Nutricia Ltd. (Danone S.A.) •Par Pharmaceutical Inc. •Pluvia AS •REGENXBIO Inc. •Retrophin, Inc. •SOMInnovation Biotech, SA •Synlogic, Inc. •Synthetic Biologics, Inc. For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/phenylketonuria-treatment-market

  4. About Orion Market Research Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. Media Contact: Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +1 646-755-7667, +91 780-304-0404

More Related